Syndax Pharmaceuticals
SNDX
SNDX
132 hedge funds and large institutions have $1.15B invested in Syndax Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+9
Holders Change %
+7.32%
% of All Funds
2.04%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
30
Increased
42
Reduced
34
Closed
20
Calls
$5.77M
Puts
$825K
Net Calls
+$4.94M
Net Calls Change
+$4.44M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$43.4M |
| 2 |
FM
2
Frazier Management
Seattle,
Washington
|
$60.7M |
| 3 |
ACA
3
Avoro Capital Advisors
New York
|
$47.6M |
| 4 |
SI
4
Sofinnova Investments
Menlo Park,
California
|
$20.8M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$10.6M |
